Investigation summary: in response to the event reported a device history review was conducted for the provided lot number.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Based on the description of the event, our engineers were able to determine that the most likely root cause for this event is the forcing of fluid through the device during injection.The bd pegasus is an infusion only device and is not rated for high pressure injections.Bd will continue to track and trend for this issue.At this time risk is determined to be low and as such, there is no need for capa.
|